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Abstract Source point treatment of effluents with a high
load of pharmaceutical active compounds (PhACs), such
as hospital wastewater, is a matter of discussion among
the scientific community. Fungal treatments have been
reported to be successful in degrading this type of pollut-
ants and, therefore, the white-rot fungus Trametes
versicolor was applied for the removal of PhACs from
veterinary hospital wastewater. Sixty-six percent removal
was achieved in a non-sterile batch bioreactor inoculated
with T. versicolor pellets. On the other hand, the study of
microbial communit ies by means of DGGE and
phylogenetic analyses led us to identify some microbial
interactions and helped us moving to a continuous pro-
cess. PhAC removal efficiency achieved in the fungal
treatment operated in non-sterile continuous mode was
44 % after adjusting the C/N ratio with respect to the
previously calculated one for sterile treatments. Fungal
and bacterial communities in the continuous bioreactors
were monitored as well.
Keywords Veterinary hospital wastewater . Continuous
treatment . Pharmaceutically active compounds .White-rot
fungi
Introduction
Pharmaceutically active compounds (PhACs) are a group
of organic micropollutants with raising concern among
the scientific community due to their low biodegradability
in activated sludge wastewater treatment (Joss et al. 2006;
Verlicchi et al. 2012), their presence in surface waters,
groundwater, and even tap water (Gros et al. 2012;
Jurado et al. 2012), and their associated risks (Verlicchi
et al. 2012). Joss et al. (2006) calculated that wastewater
dilution, and, hence, dilution of PhAC concentration is
detrimental for their biological removal by activated
sludge since pseudo first order kinetics were observed
for the biological degradation of PhACs. Therefore, treat-
ment at source point (i.e., hospital effluents) could help
increase removal of PhACs, taking into account that hos-
pital wastewaters are considered to significantly contrib-
ute to PhAC load entering the wastewater treatment plants
(WWTPs) (Santos et al. 2013). Some pieces of work deal-
ing with hospital wastewater treatment can be found in the
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literature (Kovalova et al. 2012; Verlicchi et al. 2010).
However, there is no data about the presence of PhACs
in wastewaters from veterinary hospitals.
Among all biological treatments, which are more cost-
effective than physical-chemical ones, the use of white-rot
fungi (WRF) has been extensively studied due to its abil-
ity to degrade a wide range of organic micropollutants
more efficiently than conventional biological treatments.
Some studies applying WRF for the degradation of dyes,
polycyclic aromatic hydrocarbons (PAHs), pesticides and,
most recently, a high variety of PhACs can be found in
the literature (Asgher et al. 2008; Harms et al. 2011).
However, most of them are performed at lab scale, and
there are still few studies scaling up the process set-up
from Erlenmeyer to bioreactor scale and even less work-
ing under non-sterile conditions. Some of them have dealt
with synthetic wastewater (Libra et al. 2003; Nguyen
et al. 2013) and fewer with real wastewater (Blánquez
et al. 2008; Zhang and Geissen 2012). Moreover, in most
of them, only the degradation of some spiked contami-
nants was monitored. Recently, degradation of PhACs at
pre-existent concentrations in treatments using the WRF
Trametes versicolor and dealing with real effluents, such
as urban and hospital wastewater and reverse osmosis
concentrate from a tertiary treatment in an urban
WWTP, have been reported for the first time with prom-
ising results (Badia-Fabregat et al. 2015; Cruz-Morató
et al. 2014; Cruz-Morató et al. 2013a). Some of those
studies were carried out under non-sterile conditions in
an attempt for approaching real conditions (Cruz-Morató
et al. 2014; Cruz-Morató et al. 2013a). Nonetheless, all
the experiments were in batch mode, and no continuous
treatment with real effluents at pre-existing PhAC concen-
tration has been reported so far. Moreover, in none of
them, the co-existing microbial community has been
assessed.
On the other hand, despite the advances in the recent
years, fungal treatments are still far from the optimal op-
erational conditions for treating real non-sterile effluents.
Some drawbacks, such as the growth of unwanted micro-
organisms, are not yet solved. Therefore, the aim of the
present work is to determine if PhAC degradation at al-
ready present concentrations in a fungal bioreactor is pos-
sible under non-sterile conditions for veterinary hospital
wastewater (VHW) in batch and, for the first time, in
continuous operation, with special emphasis in factors
that could improve it. Thus, some parameters affecting
degradation are discussed, such as microbial populations
and nutrient requirements. To that purpose, the bacterial
and fungal populations grown inside the bioreactors were
analyzed by means of PCR-denaturing gradient gel elec-
trophoresis (DGGE) analysis for a deeper understanding
of microbial interactions affecting T. versicolor survival.
Materials and methods
Fungus, chemicals and wastewater
Trametes versicolor (ATCC#42530) was obtained from the
American Type Culture Collection and was maintained by
subculturing on petri dishes in malt extract (2 %) and agar
(1.5 %) medium at 25 °C. Pellets production was done as
previously described by Blánquez et al. (2006).
All the pharmaceutical and the corresponding isotopically
labelled standards were of high purity grade (>90%), and they
were purchased from Sigma-Aldrich (Steinheim, Germany),
US Pharmacopeia USP (MD, USA), Europea Pharmacopeia
EP (Strasbourg, France), Toronto Research Chemicals TRC
(Ontario, Canada) and CDN isotopes (Quebec, Canada). The
individual standard solutions, as well as isotopically labelled
standard solutions, were prepared according to Gros et al.
(2012) The solvents, high-performace liquid chromatography
grade methanol, acetonitrile, water (Lichrosolv), and formic
acid (98 %), were provided by Merck (Darmstadt, Germany).
Glucose, ammonium tartrate dibasic, malt extract, and other
chemicals were purchased from Sigma-Aldrich (Barcelona,
Spain).
VHW was obtained from a veterinary hospital located in
the Universitat Autònoma de Barcelona campus (Bellatera,
Barcelona, Spain) the same day that each bioreactor was set
up and also once a week during continuous bioreactors oper-
ation. Table S1 shows wastewater characterization.
Fungal bioreactors and operating conditions
Two fungal biomass air-pulsed fluidized bed glass bioreactors
(1.5 L) (Blánquez et al. 2006) were set up in parallel for each
experiment (batch and continuous), one inoculated with
T. versicolor (B-I and C-I for batch and continuous, respec-
tively) and the other non-inoculated as a control (B-NI and C-
NI). They were filled with 1.5 L of VHW, and temperature
was set up at 25 °C, and pH was controlled to be constant at
4.5±0.5 by HCl 1 M or NaOH 1 M addition. Samples of
approximately 250 mL, collected along bioreactors operation,
were filtered by vacuum with Whatman GF/C filters and a
0.45-μm nylon filter (Millipore) from which 200 mL were
then frozen until pharmaceutical characterization, and approx-
imately 50 mL were used immediately for the other routine
analyses (check the BRoutine analyses^ section). In the batch
experiment, samples for microbial community analyses were
also collected and frozen at −20 °C in 2 mL eppendorfs with-
out any processing until DNA extraction.
Non-sterile fungal bioreactors operating in batch mode
Pellets of T. versicolor were added at 2 g L−1 dry cell weight
(DCW) concentration. Bioreactors were operated in fed-batch
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mode for nutrients supply. Glucose and ammonia tartrate were
added in pulses of 0.6 min/h from a concentrated stock at a
rate of 277 and 0.619 mg g DCW−1 day−1 respectively.
Addition rate was adjusted in order to avoid glucose accumu-
lation in the media. Samples from the bioreactors media were
taken on days 0, 7, and 15.
Non-sterile fungal bioreactors operating in continuous mode
Fungal pellets were kept inside the bioreactor by means of a
mesh. T. versicolor was initially added at 3.7 g DCW L−1.
However, every 2–5 days, approximately 1/3 of the biomass
was replaced by fresh ones as determined by Blánquez et al.
(2006). Hydraulic retention time (HRT)was 3.3 days. Initially,
glucose and ammonia tartrate were added at a rate of 343 and
0.77 mg g DCW−1 day−1, respectively in pulses of 0.6 min/h
from a concentrated stock. Nutrient addition rate was adjusted
along the process depending on the results. VHW in the feed
storage tank was replaced every 2–3 days by fresh ones stored
at 4 °C. VHW stored in the feed tank for 2–3 days is called
Bold wastewater.^ Twenty-four-hour samples (total volume of
the effluent mixed) were taken from the effluent on days 0, 5,
10, 12, 14, 15, 17, 18, 21, and 26.
Analytical methods
Pharmaceuticals quantification
The analytical procedure performed is based on the method
described by Gros et al. (2012) which allows quantification of
76 PhACs. Briefly, 50mL of sample were pre-concentrated by
solid phase extraction (SPE) using Oasis HLB (3 cc, 60 mg)
cartridges (Waters Corp. Mildford, MA, USA), which were
previously conditioned with 5 mL methanol and 5 mL HPLC
grade water. Elution was done with 6 mL of pure methanol.
The extracts were evaporated under nitrogen stream and
reconstituted with 1 mL of methanol–water (10:90 v/v).
Lastly, 10 μL of internal standard mix at 1 ng μL−1 were
added in the extracts for internal standard calibration.
Chromatographic separation was carried out with an ultra-
performance liquid chromatography system (Waters Corp.
Mildford, MA, USA), using an Acquity HSS T3 column
(50×2.1 mm i.d. 1.7 μm particle size) for the compounds
analyzed under positive electrospray ionization (PI) and an
Acquity BEH C18 column (50×2.1 mm i.d., 1.7 μm particle
size) for the ones analyzed under negative electrospray ioni-
zation (NI), both fromWaters Corporation. The UPLC instru-
ment was coupled to 5500 QqLit, triple quadrupole linear ion
trap mass spectrometer (5500 QTRAP, Applied Biosystems,
Foster City, CA, USA) with a Turbo V ion spray source. Two
MRM transitions per compound were recorded by using the
Scheduled MRM™ algorithm, and the data were acquired and
processed using the Analyst 2.1 software.
Routine analyses
Glucose concentration was measured with a biochemical an-
alyzer YSI 2700 SELECT (Yellow Spring Instruments).
Laccase activity was measured through the oxidation of 2,6-
dimetoxyphenol (DMP) by the enzyme laccase in a modified
version of the method for the determination of manganese
peroxidase of Kaal et al. (1993). The analysis process is based
on the measure of the absorbance variance at 468 nm at 30 °C
during 2 min in a Varian Cary 3 UV/Vis spectrophotometer.
The reaction was done with 600 μL of sample, 200 μL of
sodium malonate 250 mM at pH 4.5, and 50 μL of DMP
20 mM. Activity units per liter (U L−1) are defined as the
amount of DMP in micromoles per liter which are oxidized
per minute (μmol DMP L−1 min−1). The molar extinction
coefficient of DMP was considered as 24.8 mM−1 cm−1
(Wariishi et al. 1992). Biomass pellet dry weight was deter-
mined after vacuum-filtering the cultures through pre-
weighted glass-fiber filters (Whatman, Spain). The fungal
amount was determined as the constant weight at 100 °C.
Dissolved organic carbon (DOC), total suspended solids
(TSS), and volatile suspended solids (VSS) were analyzed
according to APHA (1995). The N-NH4
+ concentration and
chemical oxygen demand (COD) were analyzed by using
commercial kits LCH303 and LCK114 or LCK314, respec-
tively (Hach Lange, Germany). Clorur, nitrate, nitrite, and
sulfate anions were quantified by a Dionex ICS-2000 ionic
chromatograph. Conductivity was determined by a CRISON
MicroCM 2100 conductometer and pH by a pH meter
CRISONMicropH 2001. AMicrotox® bioluminiscence assay
with Vibrio fisheri was used to perform acute toxicity test of
filtered samples at pH 7. The 50 % effective concentration
(EC50) was measured after 15 min of exposure. Effluent tox-
icity was expressed in toxicity units (TU), calculated as TU=
100/EC50, and an effluent was considered toxic when its TU
was over 25 as it is set by local sewage disposal regulation
(Generalitat de Catalunya 2003).
Microbial community analysis
Homogenized samples were taken from the bioreactors at dif-
ferent times and stored at −20 °C. Total genomic DNA was
extracted from approximately 4 mL for each sample using the
Fast DNA® Spin kit for soil (MP Biomedicals, USA).
Bacterial 16S rRNA genes and internal transcribed spacer
(ITS) regions of fungal rRNA genes were amplified from total
genomic DNA. Both cloning and band excision methodolo-
gies were used for phylogenetic assignment of the DGGE
bands. Complete bacterial 16S rRNA genes were amplified
for cloning and sequencing by using the forward primer
Bact27-f and the universal reverse primer Uni1492-r
(Weisburg et al. 1991). In the case of fungal ITS regions, the
forward primer ITS1F (Gardes and Bruns 1993) and the
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reverse primer ITS4 (White et al. 1990) were employed. The
thermocycling programs were as described in Rodríguez-
Rodríguez et al. (2012). For DGGE analysis, PCR products
were generated using universal primers in both reactions: bac-
terial 16S rRNA gene primers U968-f and L1401-r (Nübel
et al. 1996) and the fungal rRNA primers ITS1F and ITS2
(White et al. 1990). A 40-base GC clamp was attached to
the primers U968-f and ITS1F at the 5 ′ end. The
thermocycling programs were as described in Rodríguez-
Rodríguez et al. (2012). The size and amount of PCR products
was estimated by electrophoresis in 1 % agarose gels (w/v)
using a DNA marker and SYBR®Safe or ethidium bromide
staining.
DGGE analysis of the PCR products was performed with
either a DCode system (Bio-Rad, Hercules, CA, USA) or an
INGENYphorU (Ingeny, The Netherlands) machine. Gels
containing 7.5–8 % (w/v) polyacrilamide (37.5:1 acrylamide/
bis-acrylamide) with a denaturing gradient of 30–60 % or 40–
80 %, respectively, for bacteria and 20–50 or 25–60 % for
fungi was employed. Electrophoresis was performed for
16 h at 75–85Vin TAE buffer at 60 °C. Gels were then stained
with silver nitrate and scanned in an Epson Perfection V750
PRO (Epson, USA) or with SYBR Gold (Invitrogen, Life
Technologies) when DGGE bands were excised. Excised
DGGE bands were re-amplified (22 cycles) and run in a
DGGE gel until the bands were clear enough (3–6 cycles).
For cloning procedure, fragments previously amplified by
PCR using the primers Bact27-f/Uni1492-r and ITS1F/ITS4
were purified by means of the PCR cleanup kit NucleoSpin
Extract II (Macherey-Nagel, Germany). The fragments were
then incorporated into a pGEM-T vector using the pGEM
Easy Vector Systems kit (Promega, Madison, WI, USA).
The vector was employed in the transformation of
Escherichia coli competent cells JM109 Competent Cells
(Nzytech). Positive transformants were selected after growth
in LB medium supplemented with ampicillin, IPTG, and X-
Gal. After PCR amplification with U968GC-f/L1401-r or
ITS1FGC/ITS2, clones were screened in DGGE by means
of comparing with the corresponding band patterns of the
samples. Those clones matching different bands in the total
community profile were selected, and their inserts were am-
plified by PCR using the pGEM-T vector-targeted sequencing
primers Sp6 and T7, purified (NucleoSpin Extract II kit) and
subjected to DNA sequence analysis. Inserts were bi-
directionally sequenced with the primers Sp6/T7 at Eurofins
MWG Operon (Ebersberg, Germany). Purification and se-
quencing of excised DGGE bands were performed by a com-
mercial service (Macrogen Inc., South Korea) with the ITS1F
without GC tail and R1401 primers.
For phylogenetic analysis, partial sequences were assem-
bled using the CAP application included in the BioEdit v7.0.9
software package (Hall 1999). Chimeras were checked with
Mallard 1.02 and Pintail 1.1 programs. Similarity searches for
the assembled sequences were performed using the NCBI
Blast search program within the GenBank database with
Blast algorithm. Bacterial and fungal sequences have been
submitted to the GenBank database under accession numbers
KM392022–KM392055, KM355623–KM355667, and
KM361323–KM361352. Those sequences that could not be
deposited because their length was less than 200 bp can be
found in the supplementary material (Tables S2 and S3).
Calculations and statistical analysis
For PhAC removal calculations, those compounds detected
below quantification limit (BQL) were considered to have a
concentration of ½ of the limit of quantification (LOQ) (EPA
2000). Mean and standard deviation (SD) were calculated
using Microsoft® Excel 2011 functions. One-factor analysis
of variance (ANOVA) and Student’s t tests for statistical anal-
ysis were done with Sigmaplot 11.0; differences were consid-
ered as significant at p<0.01.
Results
Non-sterile batch treatment: operational details
and PhACs degradation
Two parallel bioreactors, one inoculated with T. versicolor (B-
I) and the other one without fungi as a control (B-NI), were set
up to assess fungal biodegradation of PhACs in a VHWunder
non-sterile conditions. An increase of laccase activity (around
70 U L−1) in the fungal bioreactor on day 3 was observed, but
after 7 days, no activity was detected (Fig. S1A), which led us
to think that T. versicolorwas not active. Initially, glucose was
added at 276 mg g DCW−1 day−1 as previously calculated
(Casas et al. 2013) and was totally consumed (Fig. S1). On
day 5, glucose addition was increased to 1453 mg g
DCW−1 day−1 when pellets started to disaggregate parallel to
the laccase activity reduction. However, glucose addition rate
was reduced again on day 8 when it was observed that glucose
started to accumulate in the media. COD was around 400 mg
O2L
−1 until day 7, reaching 2930 mg O2L
−1 after glucose
input was augmented (Fig. S1A). However, it was far below
the 11,560 mg O2L
−1 of COD accumulated in the control
reactor at the end of the experiment (Fig. S1B), which indi-
cates that metabolic products accumulated in it. VHW had
very low acute toxicity, with a TU value in the Microtox®
analysis of 1.64. After the treatment, B-NI bioreactor had a
toxicity of 0.66 TU, whereas the effluent after fungal treat-
ment showed no toxicity at all.
Regarding PhACs, 76 pharmaceutical compounds and
some of their metabolites were analyzed in both bioreactors
at 3 time points: at the beginning, after 7 days, and at the end
of the treatment (15 days). They were selected according to
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their widespread presence in wastewaters (Gros et al. 2012).
Among them, 45 were detected in the VHW and/or in the
effluent of the treatments. Antibiotics, anti-inflammatories,
and analgesics were the compounds detected at higher con-
centrations (Fig. 1, initial time). Overall, antibiotics were
found at 34.4 μg L−1. The antibiotics found at highest concen-
tration were cefalexin, ciprofloxacin, metronidazole, trimeth-
oprim, and tetracycline. Analgesics and anti-inflammatories
were found at 1.16 μg L−1, with ketoprofen as the PhAC
detected at highest concentration. Psychiatric drugs were also
found among the highest concentrations (2.26 μg L−1) with
acridone, a carbamazepine metabolite, as the compound at the
highest concentration.
Table S4 shows initial concentration and removal percent-
ages of detected PhACs. In the B-I reactor, removal of 66% of
total analyzed compounds was achieved at the end of the
treatment, whereas in the control B-NI reactor, no removal
was observed (Fig. 1). Some antibiotics (with an overall re-
moval of 57% after 7 days and until 92% after 14 days in B-I,
and negligible removal in B-NI) such as ciprofloxacin, met-
ronidazole and its hydroxilated metabolite, β-blocker
carazolol, psychiatric drug diazepam, and anti-inflammatory
naproxen were totally or partially removed in the fungal bio-
reactor, whereas no removal was observed in the control bio-
reactor. Other compounds were equally degraded in B-I and
B-NI, among which were the antibiotics cefalexin and
tetracyclin, psychiatric drugs sertraline and paroxetine, lipid
regulator gemfibrozil, anti-hypertensive amlodipine, and di-
uretic furosemide. Some PhACs, like the antibiotics
dimetridazole, azythromycin, and ronidazole and psychiatric
drug olanzapine, were not significantly removed in any of the
reactors. For some compounds, such as anti-inflammatories
ketoprofen and piroxicam and β-blockers metoprolol, pro-
pranolol, and nadolol, their concentration increased after the
treatments, but more in B-I bioreactor than in B-NI.
Ketoprofen increase (until 5.7 and 2.3 μg L−1 at 15 days in
B-I and B-NI reactors, respectively) even masks degradation
of other anti-inflammatories in the overall removal
calculation. The concentration of psychiatric drug carbamaz-
epine and its metabolite acridone (detected already up to
1.07 μg L−1 initially), as well as lipid regulators atorvastatin
and pravastatin and the antibiotic ciprofloxacin, increased
preferentially in B-NI. Finally, only desloratadine was better
removed in B-NI than in B-I after 7 days.
Evolution of bacterial and fungal populations in batch
bioreactors
Results for evolution of microbial communities in the batch
bioreactors B-I and B-NI are shown in Fig. 2 and Tables 1 and
2. It can be seen that the band corresponding to T. versicolor
(F10) in B-I bioreactor almost disappeared after 15 days.
Regarding other fungi, sequences related to the Ascomycota
Fusarium, Trichoderma, Rhinocladiella, and Phialemonium
were found in the B-I at both 7 and 15 days, instead of those
related to the Basidiomycota Trichosporon, the main fungi in
the B-NI. Some yeasts affiliated to Galactomyces were also
detected at B-NI. It should be noted that higher diversity does
not imply higher concentration. In the present work, microbial
populations have only been identified but not quantified.
Regarding bacteria, microorganisms belonging to the or-
ders Burkholderiales (β-proteobacteria), Xanthomonadales
(γ-proteobacteria), and Rhizobiales (α-proteobacteria) were
detected at B-I at the sample on day 7. Bacteria profiles of
B-I and B-NI on day 15 were very similar. In both of them,
two main bands were observed, belonging to γ- and α-
proteobacteria (Enterobacteriales and Rhodospirillales,
respectively).
Non-sterile continuous treatment: operational details
and PhACs degradation
Results obtained in batch experiments encouraged us to fur-
ther treat VHW in continuous mode under non-sterile condi-
tions. The same setting of two parallel bioreactors, one inoc-
ulated with pellets of T. versicolor (C-I) and the other one non-
Fig. 1 Evolution of total PhACs
grouped by therapeutic classes in
the batch treatment inoculated
with T. versicolor (B-I) and in the
non-inoculated control bioreactor
(B-NI) at 7 and 15 days of
treatment in comparison with the
initial concentration (the same for
both reactors)
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inoculated as control (C-NI), was performed. Bioreactors were
operated at an HRT of 3.3 days. From the DGGE results of
T. versicolor predominance, cellular retention time (CRT) was
fixed between 6 and 15 days, with partial biomass renovation
every 2–5 days, depending on visual evolution of the pellets
consistency. As shown in Fig. S2A and S2B, initial addition of
glucose was 343 mg g DCW−1 day−1, in a similar amount per
DCW as in the batch bioreactors, but it was increased until
1040 mg g DCW−1 day−1, thus trying to avoid fungal lysis
(Fig. 3). However, fungal biomass was not stabilized until the
addition of a pulse of 4.9 g of ammonia tartrate on day 12 and
the following decrease in the C/N ratio in the nutrient stock
after day 19, when ammonia from the pulse was depleted. The
amount of ammonium tartrate used for the pulse and C/N ratio
in the feeding nutrient stock corresponded to the one used
when working in synthetic media (Marco-Urrea et al. 2010),
being glucose added at 480–1040 mg g DCW−1 day−1 and
ammonium tartrate at 217–433 mg g DCW−1 day−1 from
day 19 onward. Since the change in the C/N ratio on day 12
until the end of operation on day 26, the amount of fungal
biomass in the C-I reactor was stabilized. Laccase activity
oscillated between 0 and 90 U L−1 until day 19. From that
moment onward, laccase activity remained below 10 U L−1
despite being the period when fungal pellet biomass was
maintained. Acute toxicity was analyzed by Microtox®, and
TU for veterinary hospital fresh wastewater were 10, 11, and
20 for samples at initial time, 10 and 18 days, respectively.
However, all of them were below the value of 25 TU when an
effluent is considered as toxic (Generalitat de Catalunya
2003). Old wastewater stored in the storage tank decreased
their toxicity to 1–2 TU, denoting some degradation in the
storage tank. At 11 days, toxicity in the reactors was also
1–2 TU, while after 26 days, acute toxicity was totally
removed (Table S5).
Regarding PhACs degradation, no statistical significant re-
moval was detected during the operation except at the last part
of the continuous treatment (from day 21 to 26), when remov-
al in C-I bioreactor was 44 %, whereas in the C-NI, global
concentration of PhACs increased (Fig. 4). It is noteworthy
that no stationary state was achieved because different nutrient
additions were being tested during the process to determine
favorable conditions for fungal survival. Therefore, removal
data for continuous treatments were calculated at the best per-
formance point of fungal bioreactors, which was at the end of
the operation (26 days). However, the decreasing tendency in
PhAC concentration in C-I can be observed already from the
14th day, just after ammonia pulse, when lysis of T. versicolor
was stopped. Analgesics and anti-inflammatories were the
PhACs detected at higher concentration in the samplings for
continuous treatment (Table S6). Concentration decrease after
ammonia addition can be observed as well in their profile
(Fig. S3). That profile is dominated by salycilic acid, the com-
pound detected at highest concentration. Regarding antibi-
otics, their concentration was much lower than in the previous
Fig. 2 DGGE profiles of PCR
amplified a bacterial 16S rRNA
fragment and b fungal ITS
fragment. Samples are from the
non-sterile batch bioreactor. I
correspond to bioreactor
inoculated with T. versicolor and
NI to non-inoculated reactor. 0, 1,
7, and 15 correspond to the time
of sampling
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Table 1 Phylogenetic affiliation of 16S rRNA bacterial sequences corresponding to the different bands of DGGE patterns in batch and continuous
treatments
DGGE
Band
Seq.
length
Closest relativea Accession
number
Length
coverage
Identity
(%)
Class/Orderb
B-B1 1464 Klebsiella pneumoniae strain Kp52.145 FO834906 1460/1464 99 γ-Proteobacteria/
Enterobacteriales
B-B2 1465 Enterobacter sp. LRC22 JF772056 1463/1465 99 γ-Proteobacteria/
EnterobacterialesRaoultella ornithinolytica strain B6 CP004142 1462/1465
B-B3 1463 Klebsiella pneumoniae strain MBR11 JX966429 1462/1464 99 γ-Proteobacteria/
Enterobacteriales
B-B4 1469 Luteibacter sp. enrichment culture clone 35Fe215 KF287733 1464/1469 99 γ-Proteobacteria/
XanthomonadalesDyella yeojuensis strain rif200829 FJ527678 1453/1469
B-B5 1409 Uncultured Agrobacterium sp. clone CBXB23 GU569105 1395/1409 99 α-Proteobacteria/
RhizobialesAgrobacterium tumefaciens strain NBRC 15293 AB680824 1392/1409
B-B8
B-B10
1457 Burkholderia gladioli strain CACua-73 HQ023278 1456/1457
1438/1457
99 β-Proteobacteria/
Burkholderiales
B-B7 1414 Acidomonas methanolica strain: NBRC 104435 AB682176 1406/1414 99 α-Proteobacteria/
Rhodospirillales
B-B9 1414 Acidomonas methanolica strain: NBRC 104435 AB682176 1410/1414 99 α-Proteobacteria/
Rhodospirillales
C-B2 334 Uncultured bacterium clone ncd2574c06c1 JF226179 329/334 99 Unclassified proteobacteria
C-B4 339 Uncultured soil bacterium clone SM11 EU339599 334/339 99 Unclassified proteobacteria
Micavibrio aeruginosavorus EPB CP003538 298/325 92
C-B5 337 Uncultured alpha proteobacterium AB809968 337/337 100 α-Proteobacteria/
RhodospirillalesAcidocella aluminiidurans strain NBRC 104303 NR_114266 336/337 99
C-B6 351 Klebsiella sp. Enrichment culture clone F-2 KJ465989 351/351 100 γ-Proteobacteria/
EnterobacterialesKlebsiella pneumoniae str. Kp52.145 FO834906
C-B7 377 Klebsiella sp. Enrichment culture clone F-2 KJ465989 377/377 100 γ-Proteobacteria/
EnterobacterialesKlebsiella pneumoniae str. Kp52.145 FO834906
C-B8 346 Uncultured bacterium clone ZBAF2-82 HQ682040 346/347 99 Unclassified Proteobacteria
C-B9 317 Uncultured bacterium clone ZBAF2-82 HQ682040 317/317 100 Unclassified Proteobacteria
C-B10 340 Uncultured bacterium clone UVaBiofilter-V26 KJ002532 335/340 99 Verrucomicrobiae/ Verrucomicrobiales
Prosthecobacter fluviatilis strain HAQ-1 NR_041608 327/341 96
C-B11 335 Uncultured bacterium clone eff4 JN245720 331/335 99 Unclassified α-Proteobacteria
C-B12 341 Bacterium NLAE-zl-P34 JQ606884 341/341 100 Clostridia/ Clostridiales
Acetoanaerobium noterae strain NOT-3 NR_104848
C-B13 341 Acetoanaerobium sp. WJDL-Y2 KF176997 340/341 99 Clostridia/ Clostridiales
Acetoanaerobium noterae strain NOT-3 NR_104848
C-B14 353 Uncultured bacterium A1Q1_fos_291 JX649891 353/353 100 Clostridia/ Clostridiales
Acetoanaerobium noterae strain NOT-3 NR_104848 352/353 99
C-B15 335 Parachlamydia acanthamoebae UV-7 strain UV-7 NR_074972 335/335 100 Chlamydiae/ Chlamydiales
C-B16 336 Uncultured Peptostreptococcaceae
bacterium clone CatInokulum014
KJ600240 336/336 100 Clostridia/ Clostridiales
C-B17 336 Micavibrio aeruginosavorus EPB CP003538 336/336 100 Unclassified proteobacteria
C-B18 327 Micavibrio aeruginosavorus EPB CP003538 327/327 100 Unclassified proteobacteria
C-B19 338 Uncultured bacterium isolate DGGE gel band MFC7-1 EU272913 337/338 99 Clostridia/ Clostridiales
Clostridium sticklandii str. DSM 519 FP565809 335/338
C-B21 319 Uncultured alpha proteobacterium clone S-30-48 KF827415 313/319 98 Unclassified Proteobacteria
C-B22 305 Uncultured bacterium clone ncd1306f09c1 JF107942 272/307 89 Unclassified Proteobacteria
Dongia mobilis strain LM22 NR_116676 263/300 88
C-B23 331 Burkholderia sp. WR43 AB365791 327/331 99 β-Proteobacteria/
BurkholderialesBurkholderia nodosa strain Br3470 AM284972 325/331 98
C-B25 304 Uncultured Verrucomicrobiaceae bacterium
clone A03-06C
FJ542838 292/304 96 Verrucomicrobiae/
Verrucomicrobiales
C-B26 333 Burkholderia sp. WR43 AB365791 330/333 99 β-Proteobacteria/
BurkholderialesBurkholderia nodosa strain Br3470 AM284972 328/333 98
a Closest organism at GenBank and, when possible, cultured closest match
b Classified using the Ribosomal Database Project (RDP)
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sampling campaign for batch bioreactors. The compounds
detected at higher concentrations were metronidazole and its
hydroxylated metabolite, mainly in the wastewater fed during
day 18 to 26. When concentration in the entrance was lower
(days 0–18), no statistically significant degradation was ob-
served, neither in C-I nor in C-NI bioreactors. However, after
the 21st day, around 40–50 % degradation was detected in C-I
bioreactor, whereas an increase in the concentration was ob-
served in C-NI. The low biodegradable contrast media
iopromide was only detected in the entrance wastewater from
day 10 to 18. The concentration of iopromide in the effluent of
C-I and C-NI increased progressively from the 10th to 15th
day, followed by a decrease in C-I due to fungal degradation,
whereas in C-NI, it continued to increase (Fig. S3). Psychiatric
drugs had the same concentration profile in the entrance as
iopromide, with a peak of approximately 2.5 μg L−1 between
the 10th and 18th due to the increase of diazepam in the VHW.
That increase was not observed in the effluent of the reactors,
which showed a diazepam concentration of around 0.1–
0.3 μg L−1. However, diazepam degradation can not be as-
sured as adsorption in the sampling system was observed pre-
viously (Badia-Fabregat et al. 2015). Carbamazepine was nev-
er detected in the fed wastewater; however, it was detected in
the effluent of the bioreactors. Those increases in the concen-
tration of some compounds are discussed in the BRemoval of
PhACs and toxicity in the fungal treatment and importance of
the addition of external nutrients section.^ Diuretic furose-
mide was highly removed in the fungal bioreactor (83 % at
26 days), whereas its concentration increased in the C-NI re-
actor in the second half of the treatment. The H2 receptors
antagonist ranitidine was neither detected in the fresh water,
but its concentration increased in the storage tank and also in
the C-NI bioreactor. However, in the C-I bioreactor, it was
totally removed. Other changes in PhAC concentration were
detected between fresh and old wastewater in the storage tank
(Table S6). In the antihypertensives amlodipine and
irbesartan, similar deconjugation processes might occur.
Taking into account removal percentages on day 26
(Table S6), PhACs can be grouped as compounds better re-
moved in C-I than in C-NI (i.e., salicylic acid, metronidazole,
diazepam, furosemide, clopidrogel and ranitidine), equally re-
moved in both reactors (ibuprofen), and not statistically sig-
nificantly removed in any of them (ketoprofen). Among those
whose concentration increased, piroxicam, diclofenac, and
carbamazepine increased more in C-I and metronidazole-OH
increased more in C-NI.
Evolution of bacterial and fungal populations
in continuous bioreactors
Figure 5 shows the DGGE profiles of fungi and bacteria, re-
spectively. Phylogenetic affiliation of the selected bands can
be found at Tables 1 and 2. T. versicolor was detected in all
samples. Liquid sample at day 1 of C-NI was discarded for
further analysis due to PCR contamination suspicion. Other
fungi detected at C-I and C-NI bioreactors were similar, main-
ly Candida spp. and Fusarium spp. A fungus belonging to
Xylariales sp. and an unknown fungus (88 % of identity with
Ophiostoma) was grown at C-NI as well. Some sequences,
such as that belonging to F11 band, could not be cleaned
enough for sequencing. Similar bacterial communities were
also found at C-I and C-NI, as what happened with fungi.
Thus, many unclassified proteobacteria, Enterobacteriales
sp., Burkholderiales sp., and Verrucomicrobiales sp. were de-
tected.Chlamydiales sp. and Rhodospirillaleswere also found
at day 26 at C-NI. Both fungal and bacterial diversity
(accounted as diversity of DGGE bands) in the continuous
reactors increased along the treatment.
Discussion
PhAC concentration in the VHW
Although urban and human hospital wastewaters have been
extensively studied regarding PhAC concentration (Verlicchi
et al. 2012; Verlicchi et al. 2010), a VHW has been character-
ized for the first time in the present study. As shown in
Table S1, regarding physicochemical characteristics, VHW
has the same values than average urban wastewater. The ef-
fluent presented certain inter-day variability regarding PhAC
concentration, with particular peaks of high concentration of
i.e., the contrast media iopromida, the psychiatric drug diaze-
pam, the antibiotics metronidazole, cefalexin, and ciprofloxa-
cin, and the analgesic salycilic acid. However, in general, an-
tibiotics, anti-inflammatories, and analgesics were the com-
pounds detected at higher concentrations in all the samples
for both batch and continuous treatments (Fig. 1, initial time,
and Tables S4 and S5). This is in agreement with the type of
drugs mostly prescribed at the hospital, according to the vet-
erinary hospital staff. However, although not prescribed for
veterinary treatment, psychiatric drugs were also found among
the highest concentrations, even though they were lower than
those reported in hospital and urban wastewaters (Cruz-
Morató et al. 2014; Cruz-Morató et al. 2013a; Gros et al.
2012; Santos et al. 2013) because wastewater from the human
activities of the veterinary hospital was collected as well. The
overall antibiotic concentration was in the same order of mag-
nitude to what is reported for human hospitals, with an aver-
age value of 11 μg L−1 (Verlicchi et al. 2010). Ciprofloxacin
and metronidazole, the antibiotics found at highest concentra-
tions, are also among those highly detected at hospital waste-
waters (Santos et al. 2013; Verlicchi et al. 2010). Analgesics
and anti-inflammatories were at lower concentration than ex-
pected (1.16–5.66 μg L−1), since they are reported to be at
concentrations around 100 μg L−1 in hospital wastewaters
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(Cruz-Morató et al. 2014; Verlicchi et al. 2010). Overall
PhACs levels were in general lower than those reported for
hospital wastewaters (Kovalova et al. 2012; Verlicchi et al.
2010) probably due to the higher use of water (and therefore
dilution of wastewater) for cleaning the veterinary facilities,
and the fact that urine from big animals (i.e., horses) was
collected with straw and disposed separately. In conclusion,
although not an extensive sampling campaign has been carried
out for the VHW, the results hereby presented pointed that the
type of PhACs and the range of concentration in that kind of
Table 2 Phylogenetic affiliation of ITS fungal sequences corresponding to the different bands of DGGE patterns in batch and continuous treatments
DGGE band Seq. length Closest relativea Accession number Length coverage Identity (%)
B-F1 368 Galactomyces candidum strain CBS 180.33 JN974289 366/368 99
B-F2 603 Pichia guilliermondii strain S0201 EF643576 601/603 99
B-F3 552 Phialemonium curvatum strain: CBS 490.82 AB278180 547/552 99
B-F4 527 Uncultured fungus isolate RFLP27 AF461588 527/527 100
Trichosporon laibachii strain CBS 5790 EU559348 511/511
B-F5 565 Fusarium solani strain 6.M8 FJ224382 559562 99
B-F6 563 Uncultured Fusarium sp. clone PA1912 GQ280338 562/563 99
Fusarium solani culture-collection UOA/HCPF:12649 KC254048 557/565
B-F7 565 Fusarium solani culture-collection UOA/HCPF:12649 KC254048 565/565 100
B-F8 524 Uncultured eukaryote clone N414T_268 GU941914 521/524 99
Trichosporon dermatis culture-collection UOA/HCPF KC254108 519/524
B-F9 523 Trichosporonales sp. LM88 EF060462 523/524 99
Trichosporon jirovecii strain ATCC 34499 HM802131 510/510 100
B-F10 619 Trametes versicolor sample ID: MQN028 AB811868 619/619 100
B-F11 612 Rhinocladiella similis culture-collection UOA/HCPF:11700 KC254071 610/612 99
B-F12 599 Trichoderma asperellum strain ZJSX5001 JQ040323 598/599 99
C-F1 179 Candida sp. NRRLY-27161 DQ911459 164/164 100
C-F2 227 Candida palmioleophila strain ATCC 96299 KC479687 227/227 100
C-F4 188 Uncultured eukaryote clone NS31T_257 KJ182680 188/188 100
Rhodotorula mucilaginosa strain ATCC 4056 KC881070
C-F5 172 Xylariales sp. HP-2011b HE599293 172/172 100
Phialemonium curvatum strain UTHSC R-3447 AY818323 171/172 99
C-F6 172 Xylariales sp. HP-2011b HE599293 172/172 100
Phialemonium curvatum strain UTHSC R-3447 AY818323 171/172 99
C-F7 213 Exophiala sp. CCFEE 5933 JX681050 213/213 100
Exophiala equina CBS 119.23 NR_111627
C-F8 188 Fusarium solani voucher CEQCA-O0484 KC771504 188/188 100
C-F9 188 Fusarium solani voucher CEQCA-O0484 KC771504 188/188 100
C-F10 188 Uncultured soil fungus isolate DGGE gel band F3 KJ562397 188/188 100
Fusarium solani strain DAOM 215455 JN942906
C-F13 220 Trametes versicolor culture-collection ICMP:19973 KF727428 220/220 100
C-F14 202 Trametes versicolor culture-collection ICMP:19973 KF727428 202/202 100
C-F15 222 Trametes versicolor culture-collection ICMP:19973 KF727428 222/222 100
C-F16 241 Exophiala oligosperma strain MH2012-17 AB777520 239/239 100
Exophiala oligosperma CBS 725.88 NR_111134 239/240 99
C-F17 239 Exophiala oligosperma strain MH2012-17 AB777520 239/239 100
Exophiala oligosperma CBS 725.88 NR_111134 239/240 99
C-F18 212 Uncultured exophiala clone CBB3.14 KC876175 200/212 94
Exophiala moniliae CBS 520.76 NR_111448 200/215 93
C-F19 202 Heterobasidion sp. NL-2013 isolate PFC 5320 KC492958 202/202 100
Heterobasidion parviporum strain B1142 GQ162421
C-F20 201 Trichoderma asperellum strain TR08 AB935955 201/201 100
C-F21 132 Ophiostoma stenoceras strain CBS103.78 AF484449 106/121 88
a Closest organism at GenBank and, when possible, cultured closest match
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effluents can be in between those detected in urban and hos-
pital wastewater effluents and, thus, some treatment at source
point might be interesting to implement.
Removal of PhACs and toxicity in the fungal treatment
and importance of the addition of external nutrients
T. versicolor has been reported to be able to degrade a wide
range of xenobiotics, including many PhACs (Cruz-Morató
et al. 2013b). Therefore, it was inoculated in air-pulsed fluid-
ized bioreactors with the aim of achieving the degradation of
PhACs present in the VHW. However, the degradation of
PhACs needs other carbon sources, irrespective of whether
their degradation is cometabolic or not, due to their low con-
centration. Moreover, previous studies reported that C and N
already present in an urban wastewater were not enough for
the survival of T. versicolor under non-sterile conditions
(Cruz-Morató et al. 2013a). Zhang and Geissen (2012) also
pointed the need for external supply of both carbon and
nitrogen in a treatment with Phanerochaete chrysosporium,
another well-studied WRF. Therefore, glucose and ammonia
tartrate were added in the bioreactor at the previously opti-
mized minimum feed rate (Casas et al. 2013). However, those
rates were calculated in sterile conditions, and the consump-
tion of nutrients by the other microorganisms growing in the
bioreactor as well and competing with T. versicolor resulted in
them being insufficient for the survival of the innoculated
fungus. Although, removal at B-I was 66 %, whereas at B-
NI there was no removal at all. Therefore, the inoculation with
T. versicolor constituted an efficient treatment for the removal
of some of the compounds, as already reported for other
effluents (Cruz-Morató et al. 2014; Cruz-Morató et al.
2013a). As an example, metronidazole and diazepam, two
examples of hardly biodegradable PhACs that were present
in all sampled wastewaters at considerable concentration,
were better removed by the fungal bioreactor at both treat-
ments (batch and continuous).
When working in continuous mode, the increase in the
glucose and ammonium tartrate feeding rate, trying to avoid
fungal lysis (Fig. 3), did not help in the degradation of PhACs
and survival of T. versicolor. Only after the decrease in the
C/N ratio was a stable concentration of fungus maintained,
and a decrease in the total PhAC concentration was observed,
highlighting the relationship between T. versicolor, the main
fungus detected in the pellets (Fig. 5b) and the PhAC degra-
dation. Such observation points to the fact that not only the
external supply of carbon and nitrogen is important but that
also the ratio between them might affect the microorganisms
developing in the bioreactor and the chance for T. versicolor to
compete with them. Further studies in that direction should be
performed to optimize the nutrients needed in non-sterile treat-
ments in order to minimize the use of chemicals and, in addi-
tion, the economic expenditures. An advisable value to start
the optimization might be a C/N ratio of around 10 mol
C/mol N for this particular fungi and taking always into
account the features of the wastewater.
Another remarkable issue regarding PhAC removal is the
increase in the concentration of some compounds. For exam-
ple, in the continuous treatment, carbamazepine was never
detected in the fed wastewater, whereas it was detected in
the effluent of the bioreactors. Those increases have been al-
ready reported (Badia-Fabregat et al. 2015; Cruz-Morató et al.
2013a), and this aspect has been recently deeply discussed for
a similar treatment of reverse osmosis concentrate (Badia-
Fabregat et al. 2015). Deconjugation or other transformation
reactions were postulated as the main factors for the increase
of carbamazepine and ketoprofen among other compounds.
Kovalova et al. (2012) also found an increase in carbamaze-
pine concentration among other compounds after an MBR
Fig. 3 Profiles of (black circle) laccase activity and (horizontal bar)
fungal pellets concentration in T. versicolor inoculated continuous
bioreactor (C-I). Vertical dashed lines mark changes in the C/N ratio of
the added nutrients and arrows mark renovation points of 1/3 of the old
pellets by fresh biomass
Fig. 4 Total PhACs concentration in the (black circle) inlet and the
effluent of (white circle) C-I and (inverted black triangle) C-NI in the
continuous VHW treatment
2410 Appl Microbiol Biotechnol (2016) 100:2401–2415
treatment of hospital wastewater due to the combined effect of
deconjugation and low biodegradation. In the present study,
taking into account that those increases also occurred in the
non-inoculated controls, other factors beyond T. versicolor,
such as transformation by means of bacteria or other fungi
might be responsible for it. It would be very interesting to
try to include conjugated compounds in the chemical analysis
in order to be able to monitor all kind of treatments more
accurately.
In an attempt to cover the degradation or transformation of
those toxic compounds not included in the chemical analysis,
a general test for acute toxicity (Microtox) was performed.
VHW presented toxicity values between 1 and 20 TU, already
below local legislation limits (Generalitat de Catalunya 2003).
After the fungal treatments, the effluents had no toxicity at all,
which means that T. versicolorwas able to degrade those toxic
micropollutants present in the wastewater, and no toxic me-
tabolites were produced or, at least, not at significant
concentrations.
Role of T. versicolor and the competing microorganisms
in the degradation of PhACs
According to the DGGE results, the inoculated T. versicolor
was active during the first 7 days in the B-I reactor. However,
between days 7 and 15, it lost its predominance among fungi.
On the other hand, total PhAC removal during the first period
was 26%, whereas in the second period, it reached up to 66%.
These results might point out that not only T. versicolor was
the responsible for the removal of some PhACs but that some
synergies were also taking place between different organisms.
However, inoculation with the fungus might be crucial to
achieve those synergies because in the B-NI reactor, there
was no removal at all of total PhACs. In the continuous reac-
tors, the pattern seems to be the same: if there has not been
active T. versicolor in the bioreactor, no PhAC removal is
observed. That is, in the C-NI reactor, there is no significant
PhAC removal nor in the C-I reactor during the first 15 days,
when T. versicolor pellets were lysing (Fig. 3) due to the lack
Fig. 5 DGGE profiles of PCR
amplified a bacterial 16S rRNA
fragment and b fungal ITS
fragment. Samples are from the
non-sterile continuous bioreactor.
In correspond to VHW feed to the
reactors, I to bioreactor inoculated
with T. versicolor, NI to non-
inoculated reactor, and TV to
T. versicolor pure culture
samples. Numbers of the columns
correspond to the time of
sampling
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of appropriate nutrients. It was not until the change in the C/N
ratio of the nutrients, favoring the survival of T. versicolor,
that the degradation of PhACs seemed to differ from the non-
inoculated control. The detection of DGGE bands correspond-
ing to T. versicolor even when deterioration of the system was
observed (samples taken on days 6 and 10) might be due to the
partial biomass renovations (in contrast to the non-fungal ren-
ovations in batch treatment) and that analysis was based on
genomic DNA template instead of more responsive RNA
(Rajala et al. 2011).
Taking into account that PhAC degradation in the fungal
batch treatment seems to be performed by other microorgan-
isms apart from T. versicolor, especially after day 7, PCR-
DGGE analyses of bacteria and fungus were performed. The
presence of T. versicolor seems to inhibit the growth of other
fungi, especially other basidiomycetes. However, the condi-
tions in B-I reactor seemed to favor other fungi, such as
Trichoderma spp., some strains of which were previously re-
ported to inhibit T. versicolor (Bruce and Highley 1991).
Nevertheless, in the continuous treatment, Trichoderma spp.
were not significantly found at any VHW bioreactor, pointing
to some differences between batch and continuous operation
regarding the conditions for microbial community develop-
ment. Contrary to the previous work pointing toward the dom-
inance of T. versicolor over Fusarium oxysporum (Ruiz-
Dueñas andMartínez 1996), in the present study, related fungi
were detected in presence of T. versicolor. This could imply
that depending on the media conditions and other microorgan-
isms coming along in the waste water, dominant species can
and will vary case-by-case.
It can be noted that fungi growing in all the bioreactors
weremainly Ascomycetes, unlike in the B-NI treatment where
Basidiomycetes were predominant. Almost all genera of fungi
detected in both I and NI bioreactors are reported to degrade
organic pollutants. For example, Fusarium and Trichoderma
can degrade PAHs (Verdin et al. 2005) and Trichosporon can
degrade dyes (Saratale et al. 2009). Fusarium is a ubiquitous
plant pathogen fungus and was found, for example, in olive-
mill wastewater lagoons (Millán et al. 2000). Rhinochladiella
was also found there, but its growth was limited; however, in
another study, some signs of organic micropollutant transfor-
mation were provided (Fujii and Kikuchi 2005). Therefore,
taking into account that T. versicolor was overtaken by other
fungi and/or bacteria between days 7 and 15 at B-I reactor,
further degradation of PhACs might be due to the activity of
fungi belonging to the genera Fusarium, Trichoderma, and/or
Rhinocladiella. In fact, Lu et al. (2009) reported a biofilm
inoculated with a microbial consortium with decolorizing
strains Fusarium oxysporum and Candida tropicalis among
others that after 4 months in operation, the main fungi turned
out to be Candida and a non-decolorizing species of
Trichoderma. Candida spp. were present from days 6–10 on-
ward in the continuous treatments. This is in accordance with
the previous observations, as it was found to be one of the
main genera at urbanWWTP, together with Rhodotorula spp.,
Trichosporon spp., and other five unidentified genera (Yang
et al. 2011).
Regarding bacteria, B-I profile at the end of the treatment
was similar to the B-NI. The reason might be that there was
almost no T. versicolor at that point, and bacteria that might be
inhibited by T. versicolor could proliferate in the B-I bioreac-
tor as well. Those bacteria probably belonged to the genera of
Enterobacteriales and Rhodospirillales (bands of B-I 15d
were not sequenced, assignment only by position). In the sam-
ple on day 7, although there are some bands that could not be
identified, Enterobacteriales seem to be present in fewer
amounts than in the absence of T. versicolor (B-I 15d and B-
NI). That could imply that the presence of T. versicolormight
help in the elimination of pathogens belonging to the genera of
Enterobacteriales. However, there is no other reports
supporting this hypothesis, and more studies should be per-
formed in that respect. Moreover, Enterobacteria spp. were
present at each continous bioreactor, independently if it was
inoculated by T. versicolor or not. Burkholderia spp. were also
present at both continuous bioreactors and also in the batch
bioreactor. Results are consistent because Burkholderia be-
long to β-proteobacteria, which are the major populations in
environmental samples and also aerobic MBRs (Ayache et al.
2013).
No specific bacteria can be totally related with the dead of
T.versicolor around day 6 of C-I because the majority of the
bacteria detected at that moment were also present during all
the treatment, also when T. versicolor recovered. The single
band only present at days 6 and 10 was assigned to an unclas-
sified proteobacteria (band C-B2, Fig. 5a)
Regarding the possible involvement of bacteria in the deg-
radation of PhACs, as band pattern is the same at B-I 15d and
B-NI 15d, the possible role of bacteria in the fungal reactor
might be the further degradation of fungal metabolites
(Mikesková et al. 2012). In the work of Lu et al. (2009), the
main bacteria found after 4 months of operation of a biofilm
inoculated with a mixed consortium of fungi and bacteria were
α-proteobacteria (Rhizobiales and Rhodobacterales).
However, in general, there is little data in the literature regard-
ing microbial interactions between T. versicolor (or WRF in
general) and other microorganisms and, as stated before, with
contradictory results. Moreover, no relationship between cer-
tain detected microorganisms and degraded PhACs could be
established. Even regarding T. versicolor, although the overall
concentration decreased, the degradation percentages of each
compound can vary depending on the culture conditions, the
wastewater, or the initial concentration, among other factors.
In the continuous bioreactors, higher diversity was gener-
ally found at the samples of the last days of the treatment,
probably due to the much higher HRT than conventional
growht rates, which allows proliferation of many types of
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microorganisms. However, no clear DGGE pattern change
was observed between before and after the C/N ratio change
in the added nutrients. Therefore, as DGGE analysis are only
qualitative, improvement in the T. versicolor survival might be
due to quantitative differences between T. versicolor and the
other microorganisms. Thus, although this work shows some
preliminary results about microbial community development
in wastewater treatments inoculated with white-rot fungi,
more work should be done regarding multiple interactions
and activities between fungi and bacteria in fungal treatments
and their relationship with xenobiotics degradation.
Moreover, it should also be taken into account that microbial
community can be highly case-dependent, as shown in here.
Thus, in the future, analysis of many experimental data might
lead to a better correlation between operational factors and
presence of certain microorganisms, being this work one of
the first steps in that direction.
Role of laccase activity in the degradation of PhACs and as
indicator of T. versicolor activity
Laccase has been reported to be the main linginolytic extra-
cellular enzyme expressed by T. versicolor under similar cul-
ture conditions (Font et al. 2003). This does not mean that
laccase, although it can participate, is the main enzyme in-
volved in the degradation of PhACs. In fact, it was previously
reported that extracellular enzymes are not crucial for achiev-
ing good degradation percentages of xenobiotics (Blánquez
et al. 2004; Yang et al. 2013). Taking that into account, in
the present study, extracellular laccase activity was analyzed
and studied as a valid indicator for the T. versicolor activity. In
the batch treatment, a positive correlation between laccase
activity and T. versicolor survival (as shown by DGGE re-
sults) can be found. On the other hand, absence of laccase
activity does not seem to affect PhAC degradation as there
was still a significant degradation rate between days 7 and
15. Therefore, degradation could be assigned to other en-
zymes such as cytochrome P450 (Marco-Urrea et al. 2010)
or to other microorganisms growing in the bioreactor. Taking
into account the molecular biology results, it is likely to be due
to the activity of other microorganisms.
On the other hand, in the fungal continuous treatment,
laccase activity remained below 10 U L−1 after the change
of the C/N ratio in the nutrients, despite being the period when
fungal pellet biomass was maintained (T. versicolor was still
present at both pellets and liquid samples according to DGGE
analysis). It confirms, in this case, the decoupling between
fungal degradation and presence of extracellular enzymes
(Blánquez et al. 2008). Extracellular enzymes can be pro-
duced but degraded or inactivated by products from other
microorganisms (Yang et al. 2013). In conclusion, extracellu-
lar laccase might not be a good indicator of T. versicolor ac-
tivity, and it does not seem to be important for the degradation
of PhACs either (at least in our continuous operating
conditions).
Strategies for fungal survival and future perspectives
According to DGGE results of batch treatment and previous
experiments (Blánquez et al. 2006), biomass was partly
renewed every 2–5 days in the continuous treatment, depend-
ing on visual evolution, which results in a CRT between 6 and
15 days. This CRT should be optimized in the future at the
same time as the amount of nutrients and its C/N ratio. The
amount of external nutrients to keep T. versicolor alive and
active over the rest of microorganisms and to limit the reno-
vation of biomass should be found. However, addition of nu-
trients cannot be in excess for both the higher costs (even if
using waste subproducts) and the increase in the COD of the
effluent that an accumulation of metabolic products in the
media involves, as happened in the B-NI reactor (Fig. S1B
and S2B).
On the other hand, there is a lack of studies about bacterial
and fungal interactions in fungal treatments for the
degradation of xenobiotic compounds. In the present work,
microbial community analysis showed that after 15 days of
batch treatment, T. versicolor lost its predominance. However,
other fungi, such as Fusarium and Trichoderma, which could
also degrade PhACs, were detected in the inoculated reactor
but not in the control one. Strategies inoculating with some
fungal consortium, in a similar way to what Lu et al. (2009)
did, might be a good alternative and should be studied in
depth.
Therefore, further optimization on nutrient requirements
under non-sterile conditions and comprehensive studies on
the interactions between fungi and bacteria are needed, al-
though promising results regarding PhAC degradation in real
wastewaters and non-sterile conditions arise from the present
work.
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